Ethyl 5-chloro-1,3-benzothiazole-2-carboxylate

Catalog No. :
ACRBZC724
CAS No. :
857081-41-5
Molecular Formula :
C10H8ClNO2S
Molecular Weight :
241.70

IUPAC Name:ethyl 5-chlorobenzo[d]thiazole-2-carboxylate

Ethyl 5-chloro-1,3-benzothiazole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$180.00Login to see priceInquiryInquiry
1g95%$347.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-chloro-1,3-benzothiazole-2-carboxylate
IUPAC Nameethyl 5-chlorobenzo[d]thiazole-2-carboxylate
MDL No.-
Molecular FormulaC10H8ClNO2S
Molecular Weight241.70
SMILESO=C(C1=NC2=CC(Cl)=CC=C2S1)OCC
InChI KeyKPTUAFHCIKMODW-UHFFFAOYSA-N
Synonym5-CHLORO-2-BENZOTHIAZOLECARBOXYLIC ACID ETHYL ESTER;ethyl 5-chlorobenzo[d]thiazole-2-carboxylate;2-Benzothiazolecarboxylic acid, 5-chloro-, ethyl ester;Ethyl 5-Chloro-1,3-benzothiazole-2-carboxylate
CAS No.857081-41-5
PubChem CID63357893

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRBZC724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRIZY812 route compound structure diagram
    ACRIZY81257267-03-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRBZC724 route product structure diagram
    ACRBZC724857081-41-5
Inquiry

2. ACRBZC724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACYSCM803 route compound structure diagram
    ACYSCM8033507-53-7 In Stock
  4. Then
  5. ACRBZC724 route product structure diagram
    ACRBZC724857081-41-5
Inquiry

Comments (0)